Call 1 (888) 460-6556 to speak with a counselor.

Researchers at the University of Cincinnati have begun studying whether iPads with facial recognition software can verify that patients are taking medications prescribed to combat drug abuse.

The software from New York-based AiCure is designed to confirm that a patient ingested the right medication at the right time.

The clinical study involving 140 patients focuses on Suboxone, a medication prescribed as maintenance therapy for opioid addiction, said Dr. Eugene Somoza of the Cincinnati Addiction… (Source: bizjournals.com Health Care:Biotechnology headlines)

MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…

{ Comments on this entry are closed }

Table of Contents

by on November 21, 2014

Call 1 (888) 460-6556 to speak with a counselor.

Abstract
For Teens with Opioid Use Disorders, Bupe Better than Detox‐Rehab‐Relapse
Providers Should Use Insurance Mandate in Pennsylvania
DEA Investigates NFL Teams for Painkiller Abuse
Medicaid Expansion Enabled More Recovery Services in Ohio
For Suboxone, Goodbye Reckitt, Hello Spinoff Indivior
Coming up (Source: Alcoholism and Drug Abuse Weekly)

MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…

{ Comments on this entry are closed }

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

November 14, 2014

Authors: Yokell MA, Zaller ND, Green TC, Rich JD Abstract The diversion, misuse, and non-medically supervised use of buprenorphine and buprenorphine/naloxone by opioid users are reviewed. Buprenorphine and buprenorphine/naloxone are used globally as opioid analgesics and in the treatment of opioid dependency. Diversion of buprenorphine and buprenorphine/naloxone represents a complex medical and social issue, and […]

Read the full article →

Buprenorphine and buprenorphine/naloxone intoxication in children – how strong is the risk?

November 14, 2014

Authors: Soyka M Abstract Opioid maintenance therapy with methadone or buprenorphine is an established and first-line treatment for opioid dependence. Risk of diversion and toxicity of opioid prescription drugs, including buprenorphine, causes significant concerns. This is particularly the case in the United States, where the number of related emergency visits is increasing, especially in children. […]

Read the full article →

Complete Care Medical Center Now Offering Outpatient Detox Treatment…

November 11, 2014

Complete Care Medical Center is now offering outpatient detox treatment with several Certified Suboxone Doctors in South Florida. The treatment is highly effective for those suffering from addiction…(PRWeb November 11, 2014)Read the full story at http://www.prweb.com/releases/suboxone-doctors/south-florida/prweb12317157.htm (Source: PRWeb: Medical Pharmaceuticals) MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…

Read the full article →

Combined Abuse of Clonidine and Amitriptyline in a Patient on Buprenorphine Maintenance Treatment

November 1, 2014

Buprenorphine/naloxone maintenance therapy is often prescribed in primary care to treat opioid dependence. Previous reports have described concomitant abuse of opioids and clonidine. In this case, a primary care patient on buprenorphine/naloxone maintenance therapy demonstrating altered mental status, hallucinations, falls, and rebound hypertension was found to be concomitantly abusing clonidine and amitryptyline, which share metabolic […]

Read the full article →

Group Medication Management for Buprenorphine/Naloxone in Opioid-Dependent Veterans

November 1, 2014

Conclusions:This study found that veterans prescribed buprenorphine/naloxone in a group setting as part of a drug and alcohol treatment program were retained in treatment longer than veterans prescribed this medication individually. Because of inherent limitations in the study design, no causality can be determined; however, given the results found here, group medication management of buprenorphine/naloxone […]

Read the full article →

Diversion of Methadone and Buprenorphine by Patients in Opioid Substitution Treatment in Sweden: Prevalence Estimates and Risk Factors

October 28, 2014

Dependence on heroin or other opiates is a condition which is difficult to treat. Research has been unable to point to any clear evidence of lasting effects of medication-free treatment. The dominant treatment method is opioid substitution treatment (OST) with methadone or buprenorphine, the latter often combined with naloxone. Metastudies show that OST is effective […]

Read the full article →

Opioid Addicted Buprenorphine Injectors: Drug Use During And After 12-weeks of Buprenorphine-Naloxone or Methadone in the Republic of Georgia

October 19, 2014

Assess the prevalence of non-opioid drug use among opioid-addicted, buprenorphine injecting individuals in Georgia, during and after a 12-week course of buprenorphine-naloxone (Suboxone®) or methadone. (Source: Journal of Substance Abuse Treatment) MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space…

Read the full article →

Diffusion and diversion of suboxone: an exploration of illicit street opioid selling – Terry Furst R.

October 9, 2014

[Abstract unavailable] Language: en… (Source: SafetyLit: All (Unduplicated)) MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

Read the full article →